A number of states are challenging the FDA's approval of mifepristone and a 2023 decision to drop in-person dispensing requirements.
@johnshopkinssph.bsky.social Joanne Rosen breaks down Louisiana v. FDA and other cases involving mifepristone
š podcast.publichealth.jhu.edu/the-legal-ch...
